Showing 1091-1100 of 2928 results for "".
Rise of the Genomic Medicine Era in Amyotrophic Lateral Sclerosis
https://practicalneurology.com/diseases-diagnoses/neuromuscular/rise-of-the-genomic-medicine-era-in-amyotrophic-lateral-sclerosis/32024/Advances in gene-targeted therapies are positioned to transform clinical treatment for familial and sporadic amyotrophic lateral sclerosis.Pompe Disease
https://practicalneurology.com/diseases-diagnoses/child-neurology/pompe-disease/31686/New treatments, available and in development, underscore need for high degree of suspicion for Pompe disease in differential for weakness and respiratory difficulties.Digital Biomarkers in Neuromuscular Disorders: Recent Advances
https://practicalneurology.com/diseases-diagnoses/neuromuscular/digital-biomarkers-in-neuromuscular-disorders-recent-advances/35556/Digital health technologies have strong potential to aid in the study and management of neuromuscular conditions.Antibody-Mediated Inflammatory Central Nervous System Disorders of Childhood
https://practicalneurology.com/diseases-diagnoses/child-neurology/antibody-mediated-inflammatory-central-nervous-system-disorders-of-childhood/31644/There is an expanding spectrum of neurologic disease caused by antibody-mediated inflammation that is also seen during childhood.Dementia Insights: Antiamyloid Antibody Therapy in Alzheimer Disease
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/dementia-insights-antiamyloid-antibody-therapy-in-alzheimer-disease/31928/The saga continues for development of antiamyloid monoclonal antibodies, aducanumab, lecanemab, donanemab, and gantenerumab for Alzheimer disease.Emerging Therapies to Slow the Progression of Huntington Disease
https://practicalneurology.com/diseases-diagnoses/movement-disorders/emerging-therapies-to-slow-the-progression-of-huntington-disease/31936/Although clinical trial results have been disappointing, they have moved development of potential disease-modifying treatments forward.Diversity in Aging-Related Neuroimaging Research
https://practicalneurology.com/diseases-diagnoses/imaging-testing/diversity-in-aging-related-neuroimaging-research/31761/There is a truly critical need to eliminate underrepresentation in aging-related neuroimaging research.Spotlight on Sleep: Beyond the Polysomnogram—Modern Approaches to Diagnosing Sleep Apnea
https://practicalneurology.com/diseases-diagnoses/sleep/beyond-the-polysomnogram-modern-approaches-to-diagnosing-sleep-apnea/35814/The evolution from in-laboratory polysomnography to flow-based home sleep apnea testing and, more recently, wearables reflects advancements in sleep technologies and a move toward patient-centered care.Clinical Biomarker Testing for Alzheimer Disease Pathology in the Context of Amyloid-Targeting Treatments
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-biomarker-testing-for-alzheimer-disease-pathology-in-the-context-of-amyloid-targeting-treatments/67050/As blood-based biomarkers become integrated into routine practice, selecting the right test and understanding its limitations have become essential for accurate Alzheimer disease diagnosis and timely access to treatment.Muscle MRI for Neuromuscular Disorders
https://practicalneurology.com/diseases-diagnoses/neuromuscular/muscle-mri-for-neuromuscular-disorders/31687/Using muscle MRI to diagnose neuromuscular conditions requires awareness of different patterns of muscle involvement.